Search for: "Clark v. Drug Enforcement Administration"
Results 41 - 60
of 66
Sorted by Relevance
|
Sort by Date
5 Jun 2024, 2:36 pm
United States v. [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution … [read post]
18 Oct 2006, 5:26 pm
On Sept. 29, 2006, the Board issued its decisions in Oakwood Healthcare, Croft Metals, and Golden Crest, in light of the Supreme Court's decision in NLRB v. [read post]
16 Oct 2011, 6:42 pm
GRIMSLEY, Appellant, v. [read post]
15 Feb 2007, 12:25 am
Clark, 504 N.W.2d 292, 300 (Neb. 1993); Pearce v. [read post]
3 May 2012, 8:01 am
Clark. [read post]
17 Sep 2011, 2:54 pm
Second, Martin appeals the trial court’s later revocation of his probation following his failure to successfully complete drug court. [read post]
17 Sep 2011, 2:54 pm
Second, Martin appeals the trial court’s later revocation of his probation following his failure to successfully complete drug court. [read post]
25 Jul 2008, 7:04 am
, (Daily Dose of IP), 26 August: WIPO symposium on IP and multilateral agreements – Geneva: (IPKat), 11-12 September: US LSI: 4th annual conference on ‘Current issues in complex IP licensing’ – Philadelphia: (Patent Docs), 11 September/15 October: PLI seminar on developments in pharmaceutical and biotech patent law – New York/San Francisco: (Patent Docs), 15-16 September: UniForum & SAIIPL domain name ADR workshop – Centurion (South… [read post]
26 Dec 2017, 9:30 pm
Supreme Court in Kokesh v. [read post]
13 Jun 2008, 3:40 am
: (Patent Docs), Generic drug developers will continue to take advantage of global demand for lower-priced drugs, with Teva poised to maintain lead position says Goldman Sachs analyst: (GenericsWeb), Daiichi Sankyo takeover of Ranbaxy: (Profitability through Simplicity), (Spicy IP), (GenericsWeb), Canada: Generics to penetrate 26% pharma market in Canada says RNCOS research: (GenericsWeb), Canada: Generic drug makers spreading misinformation about patent regulation… [read post]
20 Jun 2008, 8:07 am
– Comments on IPEG post on Zyprexa patent case: (BLOG@IP::JUR) India takes open source approach to drug discovery: (Patent Lens), India: Is the Indian Drug Controller participating in the ACTA negotiations? [read post]
24 Apr 2024, 5:57 am
Among those Axios reported to be under discussion for senior government posts are Stephen Miller, Kash Patel, Steve Bannon, and Jeffrey Clark, who is currently under indictment in Georgia for his role in the fake electors scheme and a co-conspirator in the federal election indictment. [read post]
25 Apr 2010, 4:27 pm
Administrative Code: 1. [read post]
30 Jun 2022, 11:15 am
The Supreme Court's reversal of Roe v. [read post]
23 Mar 2023, 10:00 pm
The Center for Disease Control’s guidance, even if initially tentative and uncertain in light of the novel situation, and the Food and Drug Administration’s deployment of vaccines in record time demonstrate expertise in execution. [read post]
13 Jan 2020, 9:41 am
Clarke, 944 F.3d 243 (Dec. 6, 2019). [read post]
27 Apr 2017, 1:30 am
Rogers College of Law, Promotion of Drugs and Devices: Off-Label and No-LabelJason Smith, California State University, East Bay, Health, the First Amendment and the Ethics of the Patient-Physician Interaction Health Care Financing and Regulation Session 1B – Room 245Developments in Mental Health Parity and Addiction Equity: Enforcement, Guidance and ImplementationModerator: Paul Lombardo, Georgia State University College of LawMelissa Alexander, University of Wyoming College… [read post]
20 Aug 2007, 5:34 am
State v. [read post]
28 Mar 2008, 6:00 am
– GIs and the wine industry: (Canadian Trademark Blog) ChinaWorkTools: ‘We won the judgement but it did no good’ Part II: (IP Dragon),How should China spend its extra Yuan on IPR enforcement? [read post]
